Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Payables (2023 - 2025)

Historic Payables for Rallybio (RLYB) over the last 3 years, with Q3 2025 value amounting to $269000.0.

  • Rallybio's Payables fell 5385.93% to $269000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $269000.0, marking a year-over-year decrease of 5385.93%. This contributed to the annual value of $278000.0 for FY2024, which is 7151.64% down from last year.
  • Rallybio's Payables amounted to $269000.0 in Q3 2025, which was down 5385.93% from $119000.0 recorded in Q2 2025.
  • Rallybio's Payables' 5-year high stood at $1.2 million during Q2 2024, with a 5-year trough of $119000.0 in Q2 2025.
  • In the last 3 years, Rallybio's Payables had a median value of $470000.0 in 2024 and averaged $568000.0.
  • Its Payables has fluctuated over the past 5 years, first surged by 7677.79% in 2024, then tumbled by 9022.99% in 2025.
  • Over the past 3 years, Rallybio's Payables (Quarter) stood at $976000.0 in 2023, then plummeted by 71.52% to $278000.0 in 2024, then fell by 3.24% to $269000.0 in 2025.
  • Its Payables stands at $269000.0 for Q3 2025, versus $119000.0 for Q2 2025 and $400000.0 for Q1 2025.